Han CH - Search Results

1

Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review.

Yeo HY, Liew AC, Chan SJ, Anwar M, Han CH, Marra CA. Yeo HY, et al. Among authors: han ch. Patient Prefer Adherence. 2023 Oct 31;17:2679-2706. doi: 10.2147/PPA.S432821. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37927344 Free PMC article. Review.

2

Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand.

Yeo HY, Wong JHY, Chan SJ, Latu ATF, Han CH, Anwar M, Marra CA. Yeo HY, et al. Among authors: han ch. Patient Prefer Adherence. 2023 Dec 22;17:3525-3537. doi: 10.2147/PPA.S443217. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 38148974 Free PMC article.

3

Selective internal radiation therapy for hepatic metastases of uveal melanoma: a systematic review.

Alexander H, Wen D, Chu M, Han C, Hadden P, Thomas R, Bartlett A. Alexander H, et al. Br J Radiol. 2022 Jan 1;95(1129):20210200. doi: 10.1259/bjr.20210200. Epub 2021 Nov 10. Br J Radiol. 2022. PMID: 34757824 Free PMC article.

4

Transarterial Radioembolization for Hepatic Metastases of Pancreatic Adenocarcinoma: A Systematic Review.

Alexander HC, Nguyen CH, Chu MJJ, Tarr GP, Han CH, Thomas RH, Holden AH, Bartlett ASJR. Alexander HC, et al. Among authors: han ch. J Vasc Interv Radiol. 2022 Dec;33(12):1559-1569.e2. doi: 10.1016/j.jvir.2022.08.031. Epub 2022 Sep 7. J Vasc Interv Radiol. 2022. PMID: 36084842 Review.

5

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients.

Han CH, Khwaounjoo P, Kilfoyle DH, Hill A, McKeage MJ. Han CH, et al. BMC Cancer. 2013 Oct 25;13:495. doi: 10.1186/1471-2407-13-495. BMC Cancer. 2013. PMID: 24156389 Free PMC article. Clinical Trial.

6

Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.

Han CH, Kilfoyle DH, Hill AG, Jameson MB, McKeage MJ. Han CH, et al. Expert Opin Drug Metab Toxicol. 2016 Dec;12(12):1479-1490. doi: 10.1080/17425255.2016.1223625. Epub 2016 Aug 23. Expert Opin Drug Metab Toxicol. 2016. PMID: 27539508 Review.

7

Genetic Characterization of Brain Metastases in the Era of Targeted Therapy.

Han CH, Brastianos PK. Han CH, et al. Front Oncol. 2017 Sep 25;7:230. doi: 10.3389/fonc.2017.00230. eCollection 2017. Front Oncol. 2017. PMID: 28993799 Free PMC article. Review.

8

Improved method for quantification of intact oxaliplatin by ultra high performance liquid chromatography-inductively coupled plasma mass spectrometry: Applications to clinical and speciation studies.

Ho J, Hartinger C, McKeage M, Han C. Ho J, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Aug 1;1243:124211. doi: 10.1016/j.jchromb.2024.124211. Epub 2024 Jun 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2024. PMID: 38964135 Free article.

9

Chemotherapy-induced reversible posterior leucoencephalopathy syndrome.

Han CH, Findlay MP. Han CH, et al. Intern Med J. 2010 Feb;40(2):153-9. doi: 10.1111/j.1445-5994.2010.02168.x. Intern Med J. 2010. PMID: 20446957

10

Diagnosis and management of primary central nervous system lymphoma.

Han CH, Batchelor TT. Han CH, et al. Cancer. 2017 Nov 15;123(22):4314-4324. doi: 10.1002/cncr.30965. Epub 2017 Sep 26. Cancer. 2017. PMID: 28950405 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters